Myocyte growth in the failing heart

Surgical Clinics of North America

Volumn 84, Issue 1, 2004, Pages 161-177

  Kajstura, Jan ^a   Leri, Annarosa ^a   Castaldo, Clotilde ^a   Nadal Ginard, Bernardo ^a   Anversa, Piero ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL COUNT; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL REGENERATION; CONFOCAL MICROSCOPY; CYTOKINESIS; DISEASE COURSE; GENE AMPLIFICATION; HEART DEVELOPMENT; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; IMMUNOHISTOCHEMISTRY; MITOSIS; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; NONHUMAN; PATHOGENESIS; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 1242271342     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(03)00215-9     Document Type: Review

References (98)

1. Zak R. Development and proliferative capacity of cardiac muscle cells. Circ Res. 35:(Suppl II):1974;17-26.
2. Anversa P., Olivetti G., Melissari M., Loud A.V. Stereological measurement of cellular and subcellular hypertrophy and hyperplasia in the papillary muscle of adult rat. J Mol Cell Cardiol. 12:(8):1980;781-795.
3. Zak R. Overview of the growth process. Growth of the heart in health and disease. 1984;1-24 Raven Press, New York.
4. Grossman W., Jones D., McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 56:(1):1975;56-64.
5. Linzbach A.J. Heart failure from the point of view of quantitative anatomy. Am J Cardiol. 5:1960;370-382.
6. Astorri E., Chizzola A., Visioli O., Anversa P., Olivetti G., Vitali-Mazza L. Right ventricular hypertrophy; a cytometric study on 55 human hearts. J Mol Cell Cardiol. 2:(2):1971;99-110.
7. Astorri E., Bolognesi R., Colla B., Chizzola A., Visioli O. Left ventricular hypertrophy: a cytometric study on 42 human hearts. J Mol Cell Cardiol. 9:(3):1977;763-765.
8. Meerson F.Z., Zaletayeva T.A., Lagutchev S.S., Pshennikova M.G. Structure and mass of mitochondria in the process of compensatory hyperfunction and hypertrophy of the heart. Exp Cell Res. 36:1964;568-578.
9. McCallister B.D., Brown A.L. A quantitative study of myocardial mitochondria in experimental cardiac hypertrophy. Lab Invest. 14:1965;692-700.
10. Anversa P., Hagopian M., Loud A.V. Quantitative radioautographic localization of protein synthesis in experimental cardiac hypertrophy. Lab Invest. 64:(3):1973;441-445.
11. Anversa P., Palackal T., Sonnenblick E.H., Olivetti G., Capasso J.M. Hypertensive cardiomyopathy: myocyte nuclei hyperplasia in the mammalian rat heart. J Clin Invest. 85:(4):1990;994-997.
12. Cooper G., Tomanek R.J., Ehrhardt J.L., Marcus M.L. Chronic progressive overload of the cat right ventricle. Circ Res. 48:(4):1981;488-497.
13. Hatt P.Y., Rakusan K., Gastineau P., Laplace M., Cluzeaud F. Aorto-caval fistula in the rat. An experimental model of heart volume overloading. Basic Res Cardiol. 75:(1):1980;105-108.
14. Anversa P., Capasso J.M. Loss of intermediate-sized coronary arteries and capillary proliferation following left ventricular failure in rats. Am J Physiol. 260:(5 Pt 2):1991;H1552-H1560.
15. Batra S., Rakusan K. Geometry of capillary networks in volume overloaded rat heart. Microvasc Res. 42:(1):1991;39-95.
16. Tomanek R.J., Wessel T.G., Harrison D.G. Capillary growth and geometry during long-term hypertension and myocardial hypertrophy in dogs. Circ Res. 261:(4 Pt 2):1993;H1011-H1018.
17. Vliegen H.W., Van der Laarse A., Cornelisse C.J., Eulderink F. Myocardial changes in pressure overload-induced left ventricular hypertrophy. Eur Heart J. 12:(4):1991;488-494.
18. Olivetti G., Melissari M., Balbi T., Quaini F., Sonnenblick E.H., Anversa P. Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans. J Am Coll Cardiol. 24:(1):1994;140-149.
19. Olivetti G., Melissari M., Balbi T., Quaini F., Cigola E., Sonnenblick E.H., et al. Myocyte cellular hypertrophy is responsible for ventricular remodeling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure. Cardiovasc Res. 24:(8):1994;140-149.
20. Linzbach A.J. Herzhypertrophie und kritisches Herzgewicht. (Cardiac hypertrophy and critical heart weight). Klin Wochenschr. 26:1948;459-463.
21. Linzbach A.J. Uber das Langenwachstum der Herzmuskelfasern und ihrer Kerne in Beziehung zur Herzdilatation. (On the longitudinal growth of cardiac muscle fibers in the progression of cardiac dilatation). Virchows Arch Pathol Anat. 328:1956;165-181.
22. Olivetti G., Ricci R., Anversa P. Hyperplasia of myocyte nuclei in long-term cardiac hypertrophy in rats. J Clin Invest. 80:(6):1987;1818-1822.
23. MacLellan W.R., Schneider M.D. Genetic dissection of cardiac growth control pathways. Annu Rev Physiol. 62:2000;289-319.
24. Oh H., Taffet G.E., Youker K.A., Entman M.L., Overbeek P.A., Michael L.H., et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci USA. 98:(18):2001;10308-10313.
25. Kirshenbaum L.A., Schneider M.D. The cardiac cell cycle, pocket proteins, and p300. Trends Cardiovasc Med. 5:1995;230-233.
26. Agah R., Kirshenbaum L.A., Abdellatif M., Truong L.D., Chakraborty S., Michael L.H., et al. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest. 100:(11):1997;2722-2728.
27. Soonpaa M.H., Koh G.Y., Pajak L., Jing S., Wang H., Franklin M.T., et al. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest. 99:(11):1997;2644-2654.
28. Wollert K.C., Chien K.R. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. J Mol Med. 75:(7):1997;492-501.
29. Chien K.R. Stress pathways and heart failure. Cell. 98:(5):1999;555-558.
30. Anversa P., Nadal-Ginard B. Myocyte renewal and ventricular remodeling. Nature. 415:(6868):2002;240-243.
31. Nadal-Ginard B., Kajstura J., Leri A., Anversa P. Myocyte death, growth and regeneration in cardiac hypertrophy and failure. Circ Res. 92:(6):2003;579-582.
32. Bolli R. Regeneration of the human heart - no chimera? N Engl J Med. 346:(1):2002;55-56.
33. Dewey M.J., Martin D.W., Martin G.R., Mintz B. Mosaic mice with teratocarcinoma-derived mutant cells deficient in hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci USA. 74:(12):1977;5564-5568.
34. Fehilly C.B., Willadsen S.M., Tucker E.M. Interspecific chimerism between sheep and goat. Nature. 307:(5952):1984;634-636.
35. Hansen H.E., Sondervang A. DNA profiles of chimeric twins, TS, and MR using the single-locus-probe technique. Hum Hered. 43:(2):1993;98-102.
36. Ichinoe T., Maruya E., Saji H. Long-term feto-maternal microchimerism: nature's hidden clue for alternative donor hematopoietic cell transplantation? Int J Hematol. 76:(3):2002;229-237.
37. Nelson J.L. Microchimerism: incidental byproduct of pregnancy or active participant in human health? Trends Mol Med. 8:(3):2002;109-113.
38. Evans P.C., Lambert N., Maloney S., Furst D.E., Moore J.M., Nelson J.L. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood. 93:(6):1999;2033-2037.
39. Nelson J.L. HLA relationships of pregnancy, microchimerism and autoimmune disease. J Reprod Immunol. 52:(1-2):2001;77-84.
40. Nelson J.L. Microchimerism and autoimmune diseases. Lupus. 11:(10):2002;651-654.
41. Ichikawa N., Demetris A.J., Starlz T.E., Ye Q., Okuda T., Chun H.J., et al. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Liver Transpl. 6:(6):2000;686-702.
42. Hakemi M., Najafi I., Ganji M.R., Khosravi F., Nikbin B. Peripheral blood microchimerism in female renal recipients from male donors. Transplant Proc. 33:(5):2001;2852-2853.
43. Ko S., Deiwick A., Jager M.D., Dinkel A., Rohde F., Fischer R., et al. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat. Nat Med. 5:(11):1999;1292-1297.
44. Ko S., Dahlke M.H., Lauth O., Jager M.D., Deiwick A., Dinkel A., et al. Bone marrow aplasia induced by passenger leukocytes from heart allografts. Exp Hematol. 29:(3):2001;339-344.
45. Russell P.S., Chase C.M., Sykes M., Ito H., Shaffer J., Colvin R.B. Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol. 167:(10):2001;5731-5740.
46. Kawai T., Cosimi A.B., Wee S.L., Houser S., Andrews D., Sogawa H., et al. Effect of mixed hemopoietic chimerism on cardiac allograft survival in monkeys. Transplantation. 73:(11):2002;1757-1764. 15.
47. Wekerle T. Transplantation tolerance induced by mixed chimerism. J Heart Lung Transplant. 20:(8):2001;816-823.
48. Quaini F., Urbanek K., Beltrami A.P., Finato N., Beltrami C.A., Nadal-Ginard B., et al. Chimerism of the transplanted heart. N Engl J Med. 346:(1):2002;5-15.
49. Laflamme M.A., Meyerson D., Saffitz J.E., Murray C.E. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res. 90:(6):2002;634-640.
50. Muller P., Pfeiffer P., Koglin J., Schafers H.J., Seeland U., Janzen I., et al. Cardiomyocytes of non-cardiac origin in myocardial biopsies of human transplanted hearts. Circulation. 106:(1):2002;31-35.
51. Anversa P., Nadal-Ginard B. Cardiac chimerism: methods matter. Circulation. 106:(18):2002;e129-e131.
52. Lyman S.D., Jacobsen S.E. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 91:(4):1998;1101-1134.
53. Jiang X., Gurel O., Mendiaz E.A., Stearns G.W., Clogston C.L., Lu H.S., et al. Structure of the active core of human stem cell factor and analysis of binding to its receptor Kit. EMBO J. 19:(13):2000;3192-3203.
54. Bunting K.D., Zhou S., Lu T., Sorrentino B.P. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood. 96:(3):2000;902-909.
55. Bakos E., Evers R., Calenda G., Tusnady G.E., Szakacs G., Varadi A., et al. Characterization of the amino-terminal regions in the human multidrug resistance protein. J Cell Sci. 113:(Pt 24):2000;4451-4461.
56. van der Rijn M., Heimfeld S., Spangrude G.J., Weissman I.L. Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci USA. 86:(12):1989;4634-4638.
57. Ito C.Y., Li C.Y., Bernstein A., Dick J.E., Stanford W.L. Hematopoietic stem cell and progenitor defects in Sca-1/Ly-6A-null mice. Blood. 101:(2):2003;517-523.
58. Kissel H., Timokhina I., Hardy M.P., Rothschild G., Tajima Y., Soares V., et al. Point mutation in Kit receptor tyrosine kinase reveals essential roles for Kit signaling in spermatogenesis and oogenesis without affecting other Kit responses. EMBO J. 19:(6):2000;1312-1326.
59. Yoshida H., Kunisada T., Grimm T., Nishimura E.K., Nishioka E., Nishikawa S.I. Review: melanocyte migration and survival controlled by SCF/ c-kit expression. J Investig Dermatol Symp Proc. 6:(1):2001;1-5.
60. Austen K.F., Boyce J.A. Mast cell lineage development and phenotypic regulation. Leuk Res. 25:(7):2001;511-518.
61. Demeule M., Labelle M., Regina A., Berthelet F., Beliveau R. Isolation of endothelial cells from brain, lung and kidney: expression of the multidrug resistance P-glycoprotein isoforms. Biochem Biophys Res Commun. 281:(3):2001;827-834.
62. Geick A., Eichelbaum M., Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem. 276:(18):2001;14581-14587.
63. English A., Kosoy R., Pawlinski R., Bamezai A. A monoclonal antibody against the 66-kDa protein expressed in mouse spleen and thymus inhibits Ly-6A.2-dependent cell-cell adhesion. J Immunol. 165:(7):2000;3763-3771.
64. Asakura A., Seale P., Girgis-Gibardo A., Rudnicki M.A. Myogenic specification of side population cells in skeletal muscle. J Cell Biol. 159:(1):2002;123-134.
65. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature. 410:(6829):2001;701-705.
66. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 98:(8):2001;10344-10349.
67. Beltrami A.P., Urbanek K., Kajstura J., Yan S.-M., Finato N., Bussani R., et al. Evidence that human cardiac myocytes divide after infarction. N Engl J Med. 344:(23):2001;1750-1757.
68. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., et al. Neurogenesis in the adult human hippocampus. Nat Med. 4:(11):1998;1313-1317.
69. Jonsson Z.O., Hubscher U. Proliferating cellular antigen: more than a clamp mechanism. Bioessays. 19:(11):1997;967-975.
70. Quaini F., Cigola E., Lagrasta C., Saccani G., Quaini E., Rossi C., et al. End-stage cardiac failure in humans is coupled with the induction of PCNA and nuclear mitotic division in myocytes. Circ Res. 75:(6):1994;1050-1063.
71. Scholzen T., Gerdes J. The Ki-67 protein: from the known to the unknown. J Cell Physiol. 182:(3):2000;311-322.
72. MacCallum D.E., Hall P.A. The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell cycle. J Pathol. 190:(5):2000;537-544.
73. Endl E., Gerdes J. The Ki-67 protein: fascinating forms and unknown function. Exp Cell Res. 257:(2):2000;231-237.
74. MacCallum D.E., Hall P.A. The biochemical characterization of the DNA binding activity of pKi67. J Pathol. 191:(3):2000;286-298.
75. Antonio C., Ferby I., Wilhelm H., Jones M., Karsenti E., Nebreda A.R., et al. Xkid, a cromokinesin required for chromosome alignment on the metaphase plate. Cell. 102:(4):2000;425-435.
76. Anversa P., Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res. 83:(1):1998;1-14.
77. Anversa P., Olivetti G. Cellular basis of physiologic and pathologic myocardial growth. Page E., Fozzard H.A., Solaro R.J. Handbook of physiology. The cardiovascular system: The heart. vol. 1:2001;74-114 Oxford University Press, Oxford (UK).
78. Kajstura J., Leri A., Finato N., Di Loreto C., Beltrami C.A., Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA. 95:(15):1998;8801-8805.
79. Campisi J. Replicative senescence: an old lives' tale? Cell. 84:(4):1996;497-500.
80. Nugent C.I., Lundblad V. The telomerase reverse transcriptase: components and regulation. Genes Dev. 12:(8):1998;1073-1085.
81. Roy J., Fulton T.B., Blackburn E.H. Specific telomerase RNA residues distant from the template are essential for telomerase function. Genes Dev. 12:(20):1998;3286-3300.
82. Greider C.W. Telomeres, telomerase and senescence. Bioessays. 12:(20):1990;363-369.
83. Greider C.W., Blackburn E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required telomere repeat synthesis. Nature. 337:(6205):1989;331-337.
84. Blackburn E.H. Telomerases. Annu Rev Biochem. 61:1992;113-129.
85. Greider C.W. Telomerase is processive. Mol Cell Biol. 11:(9):1991;4572-4580.
86. Belair G.D., Yeager T.R., Lopez P.M., Reznikoff C.A. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA. 94:(25):1997;13677-13682.
87. Morales C.P., Holt S.E., Ouellette M., Kaur K.J., Yan Y., Wilson K.S., et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet. 21:(1):1999;115-118.
88. Liu L., Blasco M., Trimarchi J., Keefe D. An essential role for functional telomeres in mouse germ cells during fertilization and early development. Dev Biol. 249:(1):2002;74-84.
89. Cong Y.S., Wright W.E., Shay J.W. Human telomerase and its regulation. Microbiol Mol Biol Rev. 66:(3):2002;407-425.
90. Yui J., Chiu C.P., Lansdorp P.M. Telomerase activity in candidate stem cells from fetal liver and bone marrow. Blood. 91:(9):1998;3255-3262.
91. Leri A., Malhotra A., Liew C.-C., Kajstura J., Anversa P. Telomerase activity in rat cardiac myocytes is age and gender dependent. J Mol Cell Cardiol. 32:(3):2000;385-390.
92. Leri A., Barlucchi L., Limana F., Deptala A., Darzynkiewicz Z., Hintze T.H., et al. Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart. Proc Natl Acad Sci USA. 98:(15):2001;8626-8631.
93. Mattson M., Klapper W. Emerging roles for Telomerase in neuronal development and apoptosis. J Neurosci Res. 63:(1):2001;1-9.
94. Horner P.J., Gage F.H. Regenerating the damaged central nervous system. Nature. 407:(6807):2000;963-969.
95. Zhu X., Kumar R., Mandal M., Sharma N., Sharma H.W., Dhingra U., et al. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA. 93:(12):1996;6091-6095.
96. Buchkovich K.J., Greider C.W. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell. 7:(9):1996;1443-1454.
97. Ku W.-C., Cheng A.-J., Wang T.-C. Inhibition of telomerase activity by PKC inhibitors in human cancer cells in culture. Biochem Biophys Res Commun. 241:(3):1997;730-736.
98. Kiyono T., Foster S.A., Koop J.I., McDougall J.K., Galloway D.A., Klingelhutz A.J. Both Rb/p16 inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396:(6706):1998;84-88.